Liver Injury/Regeneration News

The American College of Gastroenterology released a new guideline on disorders of the mesenteric, portal, and hepatic veins and mesenteric and hepatic arteries, which can lead to acute liver failure, chronic liver disease, noncirrhotic portal hypertension, cirrhosis, and hepatocellular carcinoma.

Patients with current or prior hepatitis C infection were willing to engage in alcohol intervention including counseling and referral to treatment when encouraged by liver medical providers, according to data published in Hepatology.

BOSTON — Maralixibat demonstrated durable control of serum bactericidal antibody, pruritus, and xanthoma in children with Alagille syndrome, according to data from the ICONIC study presented at The Liver Meeting 2019.

BOSTON — In this exclusive video from The Liver Meeting 2019, Tarek Hassanein, MD, FAASLD, professor of medicine at UC San Diego Health and medical director of Southern California GI and Liver Centers, discusses results of a phase 2a study, which demonstrated that DUR-928 was well-tolerated and effective in patients with acute alcoholic hepatitis.

BOSTON — The commercially available botanical product kratom, often used for its psychotropic effects, was associated with several cases of liver injury, according to data presented at The Liver Meeting 2019.

SAN ANTONIO – Despite the best medical training in the world, new trainees in hepatology often lack the primary training in giving a full physical exam, according to an expert at the National Liver Conference 2019.

SAN ANTONIO — The National Liver Congress will convene October 25th, providing a broad scientific program and exhibit of products and services important for all practitioners involved in the care of patients with liver disease.

CHICAGO — Researchers determined clinical scores that assessed short-term risks for liver disease associated with isolated heart transplantation with the Fontan procedure in pediatric patients, according to a study presented at NASPGHAN 2019.

Data from a phase 2a clinical trial of DUR-928, an endogenous, small-molecule new chemical entity, for patients with alcoholic hepatitis demonstrated that the treatment led to greater reductions from baseline in bilirubin and MELD and improved Lille scores compared with a historical control group from a University of Louisville alcoholic hepatitis study, according to a company press release.

Chronic low-level fluoride exposure contributed to small reductions in kidney and liver function among adolescents, according to a recently published study. In addition, researchers found adolescents who already had poorer kidney and/or liver function may absorb more fluoride in their bodies.